This delivery order against the CRO Support for NCATS Medicinal Chemistry for Lead Optimization master IDIQ contract with the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences provides $1,000 for a kickoff conference call in support of medicinal chemistry for lead optimization. The prime contractor is Lovelace Biomedical Research Institute, located in Albuquerque, New Mexico. No set-aside designation was applied to this...
This delivery order against the CRO Support for NCATS Medicinal Chemistry for Lead Optimization master IDIQ contract with the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences provides $1,000 for a conference call kickoff meeting in support of medicinal chemistry lead optimization. The prime contractor is Southern Research Institute, located in Birmingham, Alabama. No set-aside designation was applied to this award to...
Southwest Research Institute has been awarded a $1,000 delivery order against the CRO Support for NCATS Medicinal Chemistry for Lead Optimization master IDIQ contract held by the organization. The delivery order is for a contract kickoff conference call to provide cro support services to the National Center for Advancing Translational Sciences within the Department of Health and Human Services. The firm fixed price order is to be completed by November 30, 2019 and was awarded on September 23,...
This purchase order contract was awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Curia Global Inc. (doing business as Amri) for $79,400. The contract is for X-ray crystallography studies of ALDH1A2 to crystallize two novel small molecules within the enzyme to assist with structure-based drug design as part of an ongoing medicinal chemistry campaign. Specifically, the contractor will perform X-ray crystallography...
This is a $13,300 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS) to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The contract is for X-ray crystallography studies of ALDH1A2 in complex with a small molecule inhibitor, as part of NCATS' drug discovery and development efforts. No set-aside designation was used. Curia has extensive experience supporting various...
This contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to PPD Development LP, a global contract research organization. The contract has a value of $347,500.00 and is a delivery order under the CRO Support for NCATS Bioanalytical Method Development Indefinite Delivery Contract (IDC). The contract provides clinical trial and research support services, including areas such as...
This is a $5,623,209.67 cost-plus-award-fee contract awarded by the National Cancer Institute to Alchem Laboratories Corporation, a for-profit pharmaceutical manufacturer in Alachua, Florida. The contract is for the synthesis of non-GMP small molecule samples to support the National Cancer Institute's research. It has an ultimate completion date of September 30, 2012. Alchem Laboratories is also an awardee on several indefinite delivery vehicle (IDV) contracts with the National Cancer...
The National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $240,000.00 firm fixed-price purchase order to Chemogenics Biopharma, LLC, a for-profit limited liability company, for custom synthesis and bioanalytical services to support NCATS' internal projects focused on developing small molecule inhibitors of physiological small molecule methyltransferases. The 12-month contract is not set aside and is awarded under FAR Part 13 simplified...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a $2,805,430.26 Cost Plus Fixed Fee contract to the Lovelace Biomedical Research Institute, a not-for-profit contract research organization, to perform non-clinical safety assessment of TTHX1114 to support a Fuchs Endothelial Corneal Dystrophy Investigational New Drug (IND) application. This contract was issued as a Delivery Order under the "CRO...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $827,789 firm fixed price delivery order against its CRO Support for NCATS Drug Substance Development and Manufacture master IDIQ contract to Bachem Americas, Inc. to support the manufacture of 1 kg of CGMP L-ENK in support of the Center's drug substance development and manufacture program. Performance will take place in Torrance, California over a four-year...
This delivery order against the CRO Support for NCATS Medicinal Chemistry for Lead Optimization master IDIQ contract with the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awards Alchem Laboratories Corporation $1,000 for a conference call to kick off contract performance. The firm fixed price order is for Cro Support services in support of NCATS's Medicinal Chemistry for Lead Optimization program. Work will be performed in Alachua, Florida with a completion date of November 30, 2019. No set-aside designation was applied to this order.